<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">



<DIV style="font-size: 10pt">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>

<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P align="center" style="font-size: 10pt"><B>Date of Report (Date of earliest event reported): February 9, 2009</B>

<P align="center">

<P align="center" style="font-size: 24pt"><B>Xenonics Holdings, Inc.<BR></B>
<FONT style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>Nevada</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>001-32469</B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>84-1433854</B></TD>
</TR>
<TR valign="top">
    <TD>(State or other Jurisdiction of Incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD>(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD>(IRS Employer Identification No.)</TD>
</TR>
</TABLE>

<TABLE border="0" width="100%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD style="border-bottom: 1px solid #000000"><B>3186 Lionshead Avenue<BR>Carlsbad, California<BR></B></TD>
    <TD>&nbsp;</TD>
    <TD style="border-bottom: 1px solid #000000"><B>92010</B></TD>
</TR>
<TR valign="top">
    <TD>(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD>(Zip Code)</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">Registrant&#146;s telephone number, including area code: <B>(760) 477-8900</B>


<TABLE border="0" width="30%" cellspacing="0" cellpadding="0" style="font-size: 10pt; text-align: center">
<TR>
    <TD width="100%">&nbsp;</TD>
</TR>
<TR>
    <TD nowrap style="border-bottom: 1px solid #000000"><B>&nbsp;</B></TD>
</TR>
<TR>
    <TD nowrap>(Former name or former address if changed since last report.)</TD>
</TR>
</TABLE>

<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:

<P align="left" style="font-size: 10pt">
<FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR><BR>
<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<P>
<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="left" style="font-size: 10pt"><B>Item&nbsp;5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.</B>


<P align="left" style="font-size: 10pt; text-indent: 4%">On February&nbsp;9, 2009, Xenonics Holdings, Inc. (the &#147;Company&#148;) announced that Charles W. Hunter has resigned as the
Company&#146;s Chief Executive Officer and has become a consultant to the Company, allowing him to focus on sales
initiatives for the Company&#146;s NightHunter high-intensity illumination and SuperVision high-definition night vision
products to military customers. The Company also announced that the responsibilities of Chief Executive Officer have
been assumed by the Company&#146;s Executive Committee, which consists of Chairman Alan P. Magerman, President Jeffrey P.
Kennedy, and Larry Curfiss, who was elected to the Executive Committee in January&nbsp;2009 and who previously served as the
Vice President and Director of Business Development for ITT Night Vision from 2000 until his retirement in 2007. A
copy of the Company&#146;s press release regarding the preceding matters is filed as Exhibit&nbsp;No.&nbsp;99.1 to this Current Report
on Form 8-K and is incorporated herein by reference.


<P align="left" style="font-size: 10pt; text-indent: 4%">In connection with Mr.&nbsp;Hunter&#146;s appointment as a consultant to the Company, Multivariable Solutions LLC, an entity
controlled by Mr.&nbsp;Hunter (&#147;Multivariable&#148;), and the Company entered into a Consulting Agreement dated as of February&nbsp;9,
2009. The Consulting Agreement has an initial term of one year and will automatically be extended each year for
another one-year term unless terminated by either party. The Company will pay Multivariable a monthly fee of $10,000
plus 3% of net payments received by the Company from specified purchase orders. A copy of the Consulting Agreement is
filed as Exhibit&nbsp;10.1 to this Current Report on Form 8-K, is incorporated herein by reference, and the preceding
summary of the Consulting Agreement is qualified by the full text of Exhibit&nbsp;10.1.


<P align="left" style="font-size: 10pt; text-indent: 4%">The Company and Mr.&nbsp;Curfiss entered into a Consulting Agreement dated as of February&nbsp;1, 2009. The Consulting
Agreement has a term of twenty-four months. Pursuant to the Consulting Agreement, Mr.&nbsp;Curfiss will serve as a member
of the Company&#146;s Executive Committee and will be responsible for marketing and sales of the Company&#146;s products. Mr.
Curfiss will receive a consulting fee of $15,000 per month. The Company also agreed to grant to Mr.&nbsp;Curfiss a
five-year option to purchase 125,000 shares of the Company&#146;s common stock at an exercise price of $0.73 per share. The
option will vest only if: (1)&nbsp;the gross revenues of the Company exceed $20&nbsp;million for the 2009 fiscal year; (2)&nbsp;the
Company shows a net profit of at least $500,000 for such fiscal year; and (3)&nbsp;Mr.&nbsp;Curfiss is performing services under
the Consulting Agreement on September&nbsp;30, 2009. A copy of the Consulting Agreement is filed as Exhibit&nbsp;10.2 to this
Current Report on Form 8-K, is incorporated herein by reference, and the preceding summary of the Consulting Agreement
is qualified by the full text of Exhibit&nbsp;10.2.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01. Financial Statements and Exhibits.</B>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consulting Agreement dated as of February&nbsp;9, 2009 between
Xenonics Holdings, Inc. and Multivariable Solutions LLC</TD>
</TR>
<Tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consulting Agreement dated as of February&nbsp;1, 2009 between
Xenonics Holdings, Inc. and Larry Curfiss</TD>
</TR>
<Tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Xenonics Holdings, Inc. Press Release dated February&nbsp;9, 2009</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><br>
1
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Xenonics Holdings, Inc.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">February&nbsp;13, 2009
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-bottom: 1px solid #000000">/s/ Richard S. Kay</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name: Richard S. Kay</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Chief Financial Officer</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><br>
2

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<P align="center" style="font-size: 10pt"><U><B>Exhibit&nbsp;Index </B></U>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consulting Agreement dated as of February&nbsp;9, 2009 between
Xenonics Holdings, Inc. and Multivariable Solutions LLC</TD>
</TR>
<Tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consulting Agreement dated as of February&nbsp;1, 2009 between
Xenonics Holdings, Inc. and Larry Curfiss</TD>
</TR>
<Tr><td>&nbsp;</td></tr>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Xenonics Holdings, Inc. Press Release dated February&nbsp;9, 2009</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><br>
3

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt; display: none">4




</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c81066e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 13437}]
{"company-data": {"conformed-name": "Xenonics Holdings, Inc.", "cik": "0001289550", "assigned-sic": "3640", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-32469", "film-number": "09600650"}, "business-address": {"street1": "3186 LIONSHEAD AVENUE", "city": "CARLSBAD", "state": "CA", "zip": "92010", "phone": "760.477.8900"}, "mail-address": {"street1": "3186 LIONSHEAD AVENUE", "city": "CARLSBAD", "state": "CA", "zip": "92010"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 9, 2009
Xenonics Holdings, Inc.
(Exact name of registrant as specified in its charter)
Nevada
001-32469
84-1433854
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
3186 Lionshead Avenue
Carlsbad, California
92010
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(760) 477-8900
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
On February 9, 2009, Xenonics Holdings, Inc. (the "Company") announced that Charles W. Hunter has resigned as the
Company's Chief Executive Officer and has become a consultant to the Company, allowing him to focus on sales
initiatives for the Company's NightHunter high-intensity illumination and SuperVision high-definition night vision
products to military customers. The Company also announced that the responsibilities of Chief Executive Officer have
been assumed by the Company's Executive Committee, which consists of Chairman Alan P. Magerman, President Jeffrey P.
Kennedy, and Larry Curfiss, who was elected to the Executive Committee in January 2009 and who previously served as the
Vice President and Director of Business Development for ITT Night Vision from 2000 until his retirement in 2007. A
copy of the Company's press release regarding the preceding matters is filed as Exhibit No. 99.1 to this Current Report
on Form 8-K and is incorporated herein by reference.
In connection with Mr. Hunter's appointment as a consultant to the Company, Multivariable Solutions LLC, an entity
controlled by Mr. Hunter ("Multivariable"), and the Company entered into a Consulting Agreement dated as of February 9,
2009. The Consulting Agreement has an initial term of one year and will automatically be extended each year for
another one-year term unless terminated by either party. The Company will pay Multivariable a monthly fee of $10,000
plus 3% of net payments received by the Company from specified purchase orders. A copy of the Consulting Agreement is
filed as Exhibit 10.1 to this Current Report on Form 8-K, is incorporated herein by reference, and the preceding
summary of the Consulting Agreement is qualified by the full text of Exhibit 10.1.
The Company and Mr. Curfiss entered into a Consulting Agreement dated as of February 1, 2009. The Consulting
Agreement has a term of twenty-four months. Pursuant to the Consulting Agreement, Mr. Curfiss will serve as a member
of the Company's Executive Committee and will be responsible for marketing and sales of the Company's products. Mr.
Curfiss will receive a consulting fee of $15,000 per month. The Company also agreed to grant to Mr. Curfiss a
five-year option to purchase 125,000 shares of the Company's common stock at an exercise price of $0.73 per share. The
option will vest only if: (1) the gross revenues of the Company exceed $20 million for the 2009 fiscal year; (2) the
Company shows a net profit of at least $500,000 for such fiscal year; and (3) Mr. Curfiss is performing services under
the Consulting Agreement on September 30, 2009. A copy of the Consulting Agreement is filed as Exhibit 10.2 to this
Current Report on Form 8-K, is incorporated herein by reference, and the preceding summary of the Consulting Agreement
is qualified by the full text of Exhibit 10.2.
Item 9.01. Financial Statements and Exhibits.
Exhibit No.
Description
10.1
Consulting Agreement dated as of February 9, 2009 between
Xenonics Holdings, Inc. and Multivariable Solutions LLC
10.2
Consulting Agreement dated as of February 1, 2009 between
Xenonics Holdings, Inc. and Larry Curfiss
99.1
Xenonics Holdings, Inc. Press Release dated February 9, 2009
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
Xenonics Holdings, Inc.
February 13, 2009
By:
/s/ Richard S. Kay
Name: Richard S. Kay
Title: Chief Financial Officer
2
Exhibit Index
Exhibit No.
Description
10.1
Consulting Agreement dated as of February 9, 2009 between
Xenonics Holdings, Inc. and Multivariable Solutions LLC
10.2
Consulting Agreement dated as of February 1, 2009 between
Xenonics Holdings, Inc. and Larry Curfiss
99.1
Xenonics Holdings, Inc. Press Release dated February 9, 2009
3